ES8703481A1 - Un procedimiento para la preparacion de fosfatidos de eter de glicol - Google Patents
Un procedimiento para la preparacion de fosfatidos de eter de glicolInfo
- Publication number
- ES8703481A1 ES8703481A1 ES550920A ES550920A ES8703481A1 ES 8703481 A1 ES8703481 A1 ES 8703481A1 ES 550920 A ES550920 A ES 550920A ES 550920 A ES550920 A ES 550920A ES 8703481 A1 ES8703481 A1 ES 8703481A1
- Authority
- ES
- Spain
- Prior art keywords
- residues
- alkyl
- residue
- substituted
- glycerin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 title 1
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 150000002314 glycerols Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical class N* 0.000 abstract 1
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/13—Saturated ethers containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/13—Saturated ethers containing hydroxy or O-metal groups
- C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/164—Unsaturated ethers containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE FOSFATIDOS DE ETER DE GLICOL. CONSISTENTE EN: HACER REACCIONAR UN ETER DE GLICEROL DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN PRESENCIA DE UNA BASE ORGANICA COMO LA TRIETILAMINA, PIRIDINA O COLIDINA, EN UN DISOLVENTE ORGANICO INERTE COMO BENCENO, TOLUENO O CLOROFORMO, A TEMPERATURAS ENTRE 0JC Y LA TEMPERATURA AMBIENTE; Y LUEGO CON UNA TRI-ALQUILAMINA INFERIOR PARA OBTENER LOS COMPUESTOS DE FORMULA (I). SIENDO: DOS DE LOS RADICALES R1, R2 Y R3 RADICALES ALQUILO DE 10 A 30C CON POR LO MENOS 8C EN UNA CADENA LINEAL, ESTANDO AL MENOS UNO DE ELLOS SUSTITUIDO POR AL MENOS DOS RADICALES ALQUILO DE 1 A 3 C, Y SIENDO LA SUMA DE LOS C EN LOS DOS RADICALES SUPERIOR A 20; Y EL TERCER RADICAL ES UN RADICAL -P(O)(OC)OR4 DONDE R4 ES UN RADICAL ALQUILO INFERIOR U OTROS; R11, R12 Y R13, UNO ES H Y EL RESTO RADICALES ALQUILO DE 10 A 30C; Y M ES 2 O 3. UTILES PARA SOLUBILIZAR MEDICAMENTOS LIPOSOLUBLES EN SISTEMAS ACUOSOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH128784 | 1984-03-15 | ||
CH49185 | 1985-02-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8703481A1 true ES8703481A1 (es) | 1987-02-16 |
ES550920A0 ES550920A0 (es) | 1987-02-16 |
Family
ID=25684726
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES541242A Expired ES8606233A1 (es) | 1984-03-15 | 1985-03-14 | Un procedimiento para la preparacion de fosfatidos de eter de glicol |
ES550920A Expired ES8703481A1 (es) | 1984-03-15 | 1986-01-16 | Un procedimiento para la preparacion de fosfatidos de eter de glicol |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES541242A Expired ES8606233A1 (es) | 1984-03-15 | 1985-03-14 | Un procedimiento para la preparacion de fosfatidos de eter de glicol |
Country Status (16)
Country | Link |
---|---|
US (1) | US4694084A (es) |
EP (1) | EP0154977B1 (es) |
AR (1) | AR241022A1 (es) |
AU (1) | AU574440B2 (es) |
CA (1) | CA1264162A (es) |
DE (1) | DE3570239D1 (es) |
DK (1) | DK117985A (es) |
ES (2) | ES8606233A1 (es) |
FI (1) | FI78299C (es) |
HU (1) | HU195828B (es) |
IL (1) | IL74540A (es) |
MC (1) | MC1649A1 (es) |
NO (1) | NO851006L (es) |
NZ (1) | NZ211368A (es) |
PH (1) | PH20750A (es) |
PT (1) | PT80112B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1319886C (en) | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
US4962096A (en) * | 1987-03-24 | 1990-10-09 | Nippon Chemiphar Co., Ltd. | Heterocyclic glycerol derivatives and their use as anti-hypertensive agents |
CA2033725C (en) * | 1990-01-24 | 2001-05-29 | Folker Pittrof | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid |
FR2687314A1 (fr) * | 1992-02-18 | 1993-08-20 | Oreal | Dispersion de vesicules lipidiques, composition cosmetique et/ou pharmaceutique la contenant et procede de preparation de ladite dispersion. |
AU2245295A (en) * | 1994-04-15 | 1995-11-10 | Hemagen/Pfc | Fluorochemical emulsions containing 1,3-dialkylglycerophosphoryl choline surfactants and methods of use |
JP2740153B2 (ja) * | 1995-03-07 | 1998-04-15 | エフ・ホフマン−ラ ロシユ アーゲー | 混合ミセル |
CN1268321C (zh) * | 2001-07-13 | 2006-08-09 | 那野伽利阿株式会社 | 内部包有药物的高分子胶束的冻结干燥用组合物和该胶束的制备方法 |
AU2002951216A0 (en) * | 2002-09-05 | 2002-09-19 | Dbl Australia Pty Ltd | Surfactants and lyotropic phases formed therefrom |
WO2005021046A1 (en) * | 2003-09-01 | 2005-03-10 | Fh Faulding & Co Ltd | Compositions and methods for delivery of biologically active agents |
DE102005016152A1 (de) * | 2005-04-07 | 2006-10-12 | Basf Ag | Herstellung von (Co)Tensiden durch Umsetzung von Polyolen mit Olefinen |
CA2856742A1 (en) | 2011-12-07 | 2013-06-13 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
WO2016037128A1 (en) | 2014-09-04 | 2016-03-10 | Nano Precision Medical, Inc. | Polymeric stabilizing formulations |
US12071516B2 (en) | 2014-09-04 | 2024-08-27 | Nano Precision Medical, Inc. | Polymeric stabilizing formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1202370B (it) * | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
DE2820893C2 (de) * | 1978-05-12 | 1986-02-20 | A. Nattermann & Cie GmbH, 5000 Köln | Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen |
CA1173360A (en) * | 1979-06-22 | 1984-08-28 | Jurg Schrank | Pharmaceutical preparations |
DE3011738A1 (de) * | 1980-03-26 | 1981-10-01 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Neue glycerin-3-phosphorsaeurehalogenalkylester |
IL64397A0 (en) * | 1981-01-07 | 1982-02-28 | Weder Hans G | Process for the preparation of liposomal medicaments |
US4493832A (en) * | 1981-07-03 | 1985-01-15 | Fujisawa Pharmaceutical Co., Ltd. | Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same |
US4562179A (en) * | 1982-04-19 | 1985-12-31 | Fujisawa Pharmaceutical Co., Ltd. | Phospholipid derivatives, and pharmaceutical composition of the same |
JPS59163389A (ja) * | 1983-03-07 | 1984-09-14 | Takeda Chem Ind Ltd | リン脂質 |
JPS59184195A (ja) * | 1983-04-04 | 1984-10-19 | Takeda Chem Ind Ltd | グリセロ−ル誘導体 |
-
1985
- 1985-02-25 CA CA000475022A patent/CA1264162A/en not_active Expired - Fee Related
- 1985-03-07 IL IL74540A patent/IL74540A/xx unknown
- 1985-03-08 US US06/709,871 patent/US4694084A/en not_active Expired - Fee Related
- 1985-03-08 NZ NZ211368A patent/NZ211368A/xx unknown
- 1985-03-11 AU AU39710/85A patent/AU574440B2/en not_active Ceased
- 1985-03-12 FI FI850972A patent/FI78299C/fi not_active IP Right Cessation
- 1985-03-12 DE DE8585102830T patent/DE3570239D1/de not_active Expired
- 1985-03-12 EP EP85102830A patent/EP0154977B1/de not_active Expired
- 1985-03-13 MC MC851758A patent/MC1649A1/xx unknown
- 1985-03-13 HU HU85923A patent/HU195828B/hu not_active IP Right Cessation
- 1985-03-13 AR AR299731A patent/AR241022A1/es active
- 1985-03-14 NO NO851006A patent/NO851006L/no unknown
- 1985-03-14 DK DK117985A patent/DK117985A/da not_active Application Discontinuation
- 1985-03-14 PT PT80112A patent/PT80112B/pt not_active IP Right Cessation
- 1985-03-14 PH PH31985A patent/PH20750A/en unknown
- 1985-03-14 ES ES541242A patent/ES8606233A1/es not_active Expired
-
1986
- 1986-01-16 ES ES550920A patent/ES8703481A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PT80112A (en) | 1985-04-01 |
AU3971085A (en) | 1985-09-19 |
EP0154977A2 (de) | 1985-09-18 |
NO851006L (no) | 1985-09-16 |
AR241022A1 (es) | 1991-04-30 |
CA1264162A (en) | 1990-01-02 |
HU195828B (en) | 1988-07-28 |
EP0154977A3 (en) | 1986-02-19 |
IL74540A (en) | 1989-02-28 |
IL74540A0 (en) | 1985-06-30 |
NZ211368A (en) | 1988-11-29 |
FI78299B (fi) | 1989-03-31 |
ES8606233A1 (es) | 1986-04-16 |
PH20750A (en) | 1987-04-02 |
PT80112B (en) | 1987-03-24 |
FI850972A0 (fi) | 1985-03-12 |
MC1649A1 (fr) | 1986-04-07 |
DK117985D0 (da) | 1985-03-14 |
DE3570239D1 (en) | 1989-06-22 |
FI78299C (fi) | 1989-07-10 |
DK117985A (da) | 1985-09-16 |
ES541242A0 (es) | 1986-04-16 |
HUT36824A (en) | 1985-10-28 |
EP0154977B1 (de) | 1989-05-17 |
FI850972L (fi) | 1985-09-16 |
US4694084A (en) | 1987-09-15 |
AR241022A2 (es) | 1991-04-30 |
ES550920A0 (es) | 1987-02-16 |
AU574440B2 (en) | 1988-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES483767A1 (es) | Procedimiento para producir n-arilsulfonil-l-argininamidas | |
ES8703481A1 (es) | Un procedimiento para la preparacion de fosfatidos de eter de glicol | |
FI810389L (fi) | Foerfarande foer framstaellning av substituerade imidazolderivat | |
HUT38950A (en) | Process for producing 2-substituted-1,3-propylidene-diphosphonate derivatives and pharmaceutical compositions containing them as active agents | |
IE801440L (en) | Insecticidally active acyl-ureas. | |
ES457805A1 (es) | Un procedimiento para la preparacion de derivados de tiou- rea. | |
ES8701174A1 (es) | Un metodo de preparacion de un compuesto de tiadiazina | |
ES468658A1 (es) | Un procedimiento para preparar 4-alcohiltio-2-trifluorome- tilalcanosulfonanilidas y sus derivados | |
JPS5781469A (en) | Antifungal ethenylimidazole derivative, manufacture, pharmaceutical composition containing same, intermediate useful for manufacture and manufacture of said intermediate | |
KR840008015A (ko) | 2-시아노이미다조피리딘 유도체류의 제조방법 | |
AU539348B2 (en) | 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives | |
MY110098A (en) | Herbicidal composition and weeding method | |
SE7902867L (sv) | Antikomplementera medel | |
ES481057A1 (es) | Procedimiento para preparar una composicion protectora de - plantas que comprende como antidoto un derivado de 1,4-oxa- za-spirohidrocarburo. | |
ES535903A0 (es) | Procedimiento de preparacion de derivados de nitrosoureas | |
AU555893B2 (en) | (1,2)-heterofused-1,4-benzodiazepine | |
ES8704459A1 (es) | Procedimiento para la obtencion de acemetacina. | |
ES8106714A1 (es) | Procedimiento de preparar derivados 1,2,4-oxadiacinicos | |
EP0143440A3 (en) | Insecticidal composition | |
EP0144441A4 (en) | BLOOD PRESSURE REGULATING AGENCY. | |
IE892884L (en) | Microbicides | |
HUT34678A (en) | Insecticid,miticide and nematocide compositions containing new esters of phosphoric acid as active ingredients and process for producing the active ingredients | |
ES8102110A1 (es) | Procedimiento para la preparacion de acido 1,2,3-tiadiazol- 5-il-tioglicolico | |
Youngdale et al. | 2A, 2B-Dihomo-15-alkyl-PGE 1 analogs | |
ES8107202A1 (es) | Procedimiento para preparar nuevos derivados de oxadiazolin-1,3,4-ona-5. |